Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity.
The bacterium Porphyromonas gingivalis is a major etiologic agent in the pathogenesis of adult periodontitis in humans. Cysteine proteinases produced by this pathogen, termed gingipains, are considered to be important virulence factors. Among many other potentially deleterious activities, arginine-specific gingipains-R (RgpB and HRgpA) efficiently activate coagulation factors. To further expand knowledge of the interaction between gingipains and the clotting cascade, this study examined their effects on cellular components of the coagulation system. The enzymes induced an increase in intracellular calcium in human platelets at nanomolar concentrations and caused platelet aggregation with efficiency comparable to thrombin. Both effects were dependent on the proteolytic activity of the enzymes. Based on desensitization studies carried out with thrombin and peptide receptor agonists, and immunoinhibition experiments, gingipains-R appeared to be activating the protease-activated receptors, (PAR)-1 and -4, expressed on the surface of platelets. This was confirmed by the finding that HRgpA and RgpB potently activated PAR-1 and PAR-4 in transfected cells stably expressing these receptors. Cumulatively, the results indicate the existence of a novel pathway of host cell activation by bacterial proteinases through PAR cleavage. This mechanism not only represents a new trait in bacterial pathogenicity, but may also explain an emerging link between periodontitis and cardiovascular disease. (Blood. 2001;97:3790-3797)
Lourbakos
A
A
Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia.
Yuan
Y P
YP
Jenkins
A L
AL
Travis
J
J
Andrade-Gordon
P
P
Santulli
R
R
Potempa
J
J
Pike
R N
RN
D018829:Adhesins, Bacterial; D000818:Animals; D016866:Bacteroidaceae Infections; D001792:Blood Platelets / Q000166:cytology / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000209:etiology; D002461:Cell Line, Transformed; D003546:Cysteine Endopeptidases / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology*; D000080867:Gingipain Cysteine Endopeptidases; D006388:Hemagglutinins / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D051379:Mice; D010518:Periodontitis / Q000150:complications / Q000382:microbiology; D010974:Platelet Aggregation / Q000187:drug effects*; D016966:Porphyromonas gingivalis / Q000201:enzymology*; D011485:Protein Binding; D044463:Receptor, PAR-1; D044464:Receptor, PAR-2; D018179:Receptors, Thrombin / Q000819:agonists / Q000378:metabolism*; D014162:Transfection
D018829:Adhesins, Bacterial; D000080867:Gingipain Cysteine Endopeptidases; D006388:Hemagglutinins; D044463:Receptor, PAR-1; D044464:Receptor, PAR-2; D018179:Receptors, Thrombin; D003546:Cysteine Endopeptidases; D002118:Calcium